An analysis of the multiplicity of the effects of antilymphocyte serum. A comparison with the action of other immunosuppressive agents in the cell-mediated immune response and non-specific inflammation

J L Turk et al. Antibiot Chemother. 1969.

. 1969:15:267-94.

doi: 10.1159/000386786.

No abstract available

Cited by

Antilymphocytic serum--its constitution, effect and mode of action.
James K. James K. Proc R Soc Med. 1970 Sep;63(9):951-3. doi: 10.1177/003591577006300939. Proc R Soc Med. 1970. PMID: 4991014 Free PMC article. No abstract available.
Professor Derek Albert Willoughby (1930-2004).
Rainsford KD. Rainsford KD. Inflammopharmacology. 2005;12(5-6):407-39. doi: 10.1163/156856005774382779. Inflammopharmacology. 2005. PMID: 16259705 No abstract available.
Editorial: Current status of antilymphocyte globulin.
[No authors listed] [No authors listed] Br Med J. 1975 Mar 22;1(5959):644-5. doi: 10.1136/bmj.1.5959.644. Br Med J. 1975. PMID: 1092410 Free PMC article. No abstract available.
Substituted 9-benzyladenines: inhibitors of inflammation associated with the delayed hypersensitivity skin reaction.
Wojnar RJ, Brittain RJ. Wojnar RJ, et al. Agents Actions. 1975 May;5(2):152-60. doi: 10.1007/BF02027357. Agents Actions. 1975. PMID: 1155303
The inhibition of formation of migration inhibiting factor (MIF) by various antilymphocyte sera.
Pekárek J, Svejcar J, Johanovský J. Pekárek J, et al. Immunology. 1971 Jun;20(6):895-900. Immunology. 1971. PMID: 5314711 Free PMC article.